These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1622178)

  • 21. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of fluconazole in human plasma by micellar electrokinetic capillary chromatography with detection at 190 nm.
    von Heeren F; Tanner R; Theurillat R; Thormann W
    J Chromatogr A; 1996 Sep; 745(1-2):165-72. PubMed ID: 8843685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group.
    Haubrich RH; Haghighat D; Bozzette SA; Tilles J; McCutchan JA
    J Infect Dis; 1994 Jul; 170(1):238-42. PubMed ID: 8014509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid.
    Madu A; Cioffe C; Mian U; Burroughs M; Tuomanen E; Mayers M; Schwartz E; Miller M
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2111-5. PubMed ID: 7811028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid/liquid extraction using 96-well plate format in conjunction with hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the analysis of fluconazole in human plasma.
    Eerkes A; Shou WZ; Naidong W
    J Pharm Biomed Anal; 2003 Apr; 31(5):917-28. PubMed ID: 12684104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
    Saag MS; Powderly WG; Cloud GA; Robinson P; Grieco MH; Sharkey PK; Thompson SE; Sugar AM; Tuazon CU; Fisher JF
    N Engl J Med; 1992 Jan; 326(2):83-9. PubMed ID: 1727236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study.
    Kim SS; Im HT; Kang IM; Lee HS; Lee HW; Cho SH; Kim JB; Lee KT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):174-9. PubMed ID: 17275423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid-phase extraction of isosorbide dinitrate and two of its metabolites from plasma for gas chromatographic analysis.
    Gremeau I; Sautou V; Pinon V; Rivault F; Chopineau J
    J Chromatogr B Biomed Appl; 1995 Mar; 665(2):399-403. PubMed ID: 7795821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
    Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
    N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of fluconazole in sebum.
    Zimmermann T; Laufen H; Yeates RA; Scharpf F
    Int J Clin Pharmacol Ther; 2001 Sep; 39(9):389-94. PubMed ID: 11563685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography.
    Majcherczyk PA; Moreillon P; Decosterd LA; Sanglard D; Bille J; Glauser MP; Marchetti O
    J Pharm Biomed Anal; 2002 May; 28(3-4):645-51. PubMed ID: 12008144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography.
    Rex JH; Hanson LH; Amantea MA; Stevens DA; Bennett JE
    Antimicrob Agents Chemother; 1991 May; 35(5):846-50. PubMed ID: 1854166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS.
    Panomvana Na Ayudhya D; Thanompuangseree N; Tansuphaswadikul S
    Clin Pharmacokinet; 2004; 43(11):725-32. PubMed ID: 15301576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
    Bozzette SA; Larsen RA; Chiu J; Leal MA; Jacobsen J; Rothman P; Robinson P; Gilbert G; McCutchan JA; Tilles J
    N Engl J Med; 1991 Feb; 324(9):580-4. PubMed ID: 1992319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing.
    Witt MD; Lewis RJ; Larsen RA; Milefchik EN; Leal MA; Haubrich RH; Richie JA; Edwards JE; Ghannoum MA
    Clin Infect Dis; 1996 Feb; 22(2):322-8. PubMed ID: 8838190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of fluconazole in cryptococcal meningitis.
    Jones PD; Marriott D; Speed BR
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):235S-238S. PubMed ID: 2556240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitive bioassay for determination of fluconazole concentrations in plasma using a Candida albicans mutant hypersusceptible to azoles.
    Marchetti O; Majcherczyk PA; Glauser MP; Bille J; Moreillon P; Sanglard D
    Antimicrob Agents Chemother; 2001 Mar; 45(3):696-700. PubMed ID: 11181345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
    Debruyne D
    Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of fluconazole following intravenous and oral administration and body fluid concentrations of fluconazole following repeated oral dosing in horses.
    Latimer FG; Colitz CM; Campbell NB; Papich MG
    Am J Vet Res; 2001 Oct; 62(10):1606-11. PubMed ID: 11592327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.